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Most colorectal cancers arise from adenomatous polyps and sessile serrated lesions.
Screening colonoscopy and therapeutic polypectomy can potentially reduce colorectal
cancer burden by early detection and removal of these polyps, thus decreasing colorectal
cancer incidence and mortality. Most endoscopists are skilled in detecting and removing
the vast majority of polyps endoscopically during a routine colonoscopy. Polyps can be
considered “complex” based on size, location, morphology, underlying scar tissue, which
are not amenable to removal by conventional endoscopic polypectomy techniques. They
are technically more challenging to resect and carry an increased risk of complications.
Most of these polyps were used to be managed by surgical intervention in the past.
Rapid advancement in endoscopic resection techniques has led to a decreasing role
of surgery in managing these complex polyps. These endoscopic resection techniques
do require an expert in the field and advanced equipment to perform the procedure. In
this review, we discuss various advanced endoscopic techniques for the management
of complex polyps.
Keywords: colorectal polyp, colorectal cancer, endoscopic mucosal resection, endoscopic submucosal
dissection, colonoscopy

INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer diagnosed in both men and women in
the United States each year (1, 2). In 2020, it was estimated that 149,500 adults were diagnosed
with CRC. In terms of mortality, CRC ranks second as a cause of cancer mortality in both men
and women combined, accounting for ∼53,200 deaths in 2020 (2). The modifiable risk factors in
CRC include smoking, high alcohol consumption, unhealthy diet, physical inactivity, and excessive
weight attributing to more than half of cases of CRC (2). Most cases are preventable by appropriate
screening and surveillance (3, 4).
The adenoma to carcinoma sequence is a well-established phenomenon in which normal colonic
epithelium undergoes a series of genetic mutations that lead to cytological dysplasia and cancer
(5, 6). The pathogenesis of genetic instability in CRC involves three major pathways: chromosomal
instability (CIN), microsatellite instability (MSI), and CpG island methylator phenotype (CIMP)
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pathways (7). It is a slow process, usually takes 10–20 years,
allowing effective detection of these polyps by screening
colonoscopy (8). This sequence can be interrupted by
polypectomy, thus decreasing the incidence and mortality
from CRC (9–11). Although majority of CRC (70%) arises
from adenomatous polyps, in about 25–30% of the cases, CRC
develops from sessile serrated lesions (SSL) through the SSL-tocarcinoma pathway, mostly from the right colon. Most of the
current literature on colon polyp progression to cancer is based
on adenoma-carcinoma sequence, and thus in review, most of
the information is inclined toward adenomatous polypectomy
removal. Further changes will likely be seen in the future as more
data emerges on the SSL to cancer pathways (12, 13).
The key variable in CRC prevention is polypectomy. There is
no data from randomized controlled trials (RCT) to determine
the effect of polypectomy on CRC incidence and mortality. The
National Polyp Study is a pivotal study which provided strong
evidence that polypectomy prevents CRC (9). In the National
Polyp Study, 1,418 patients were included who had at least
one adenoma resected during the colonoscopy and they were
followed for a mean of 6 years. The incidence of CRC in the
study cohort was significantly lower (76%) than expected on the
basis of the rate in the Surveillance Epidemiology and End Results
group. Furthermore, no CRC deaths were reported. In the longterm National Polyp Study follow-up study of 2,602 patients, the
CRC mortality was reduced by 53% (95% CI 20–74%), when
compared to the Surveillance Epidemiology and End Results
population when followed for 23 years after polypectomy (10). A
population based study from Germany showed that colonoscopy
and polypectomy resulted in decreased CRC incidence and
mortality, 10 years after the inclusion of colonoscopy to the
national cancer screening program (14). There are three ongoing
European Polyp Surveillance (EPoS) studies investigating the
optimal surveillance strategies following adenoma and serrated
polyp removal. EPOS I and II are randomized controlled trials,
and EPOS III is observational. In EPOS I, 13,766 patients with
low-risk adenomas (1–2 tubular adenomas of size <10 mm with
low-grade dysplasia) are randomized to surveillance after 5 and
10 years or 10 years only. In EPOS II, 13,704 patients with highrisk adenomas (3–10 adenomas or adenomas ≥10 mm or with
high-grade dysplasia or >25% villous features) are randomized
to surveillance after 3, 5, and 10 years or 5 and 10 years only.
EPOS III is an observational study where patients with serrated
polyps ≥10 mm at any colorectal location or serrated polyps
≥5 mm proximal to the splenic flexure will undergo surveillance
colonoscopy, 5 and 10 years after baseline colonoscopy. The
primary endpoint of EPoS trials is the incidence of CRC, and it
will be compared in all three different arms. This is the first longterm randomized trial to address surveillance after colorectal
polyp removal (15).
More than 90% of polyps detected during screening
colonoscopies are small (<10 mm in size), mostly benign, and do
not contain advanced disease. These can be easily managed by
conventional cold forceps or by snare polypectomy (12, 16–18).
Around 10–15% of colorectal polyps are considered “complex”
as they are difficult to be appropriately removed with these
conventional endoscopic methods due to their size, location,
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and morphology. This review aims to discuss complex polyps
and provides in depth overview of different endoscopic methods
for removing these complex polyps. We also discuss various
complications associated with these procedures and also future
directions in the field.

COMPLEX POLYP
Complex colon polyps are generally characterized as any lesion
whose endoscopic resection is technically challenging due to the
size (>20 mm), the shape (flat/bulky), extent (polyps crossing
two haustral folds, and polyps occupying more than a third
of lumen circumference), location (right side, ileocecal valve,
dentate line), or due to the presence of fibrosis as a consequence
of large laterally spreading lesions (LSL) or previous attempts of
endoscopic resection (ER) (19–25). These complex polyps carry
an increased risk of colorectal cancer, high recurrence rates in the
range of 10–20% after piecemeal resection, risk of adverse events
with resection, increased risk of interval cancer after incomplete
resection, and potential for increased medicolegal risks (26, 27).
Approximately 10% of polyps are incompletely resected,
mainly due to size and morphology, which might contribute
to interval cancer (28). Most large polyps can be effectively
and safely resected by advanced endoscopic techniques, such
as endoscopic mucosal resection (EMR) and submucosal
endoscopic dissection (ESD) (12). These techniques are usually
indicated when polyps are confined to the colonic mucosa
(epithelium, lamina propria, and muscularis mucosa), an area
where there is no lymphatic drainage, and the risk of lymph node
metastasis (LNM) is extremely low (29). Selected superficially
invasive cancers can also be resected by en-bloc EMR or ESD.
Endoscopic resection of unrecognized malignant polyps with
superficial submucosal invasive cancer (SMIC), with subsequent
surgical resection, is not associated with increased risk of lymph
node metastasis recurrence or decreased long-term recurrencefree survival, even with high-risk histologic features (30, 31).
Malignant polyps, those which invade the submucosa
(submucosal invasive cancer–SMIC) but do not extend into the
muscularis propria (T1 on TNM classification), have a prevalence
of about 0.2–5% (32). In large, non-pedunculated polyps, SMIC
is seen in about 15% of polyps, with less than half having deep
submucosal invasion (33).

Classification of Polyps
Detailed endoscopic assessment of a lesion with high-definition
imaging is a critical first step for the optimal management
of colorectal polyps. However, high-definition white light
evaluation alone for features such as fold convergence, edge
retraction, expansion/thickened folds, firm consistency,
erythema is not enough for an assessment of SMIC. Increasing
size, recto-sigmoid location, and surface morphology have
been associated with an increased risk of SMIC (34–36).
Lateral spreading lesions (LSL), polyps that spread laterally and
circumferentially rather than vertically, are commonly seen in
practice (Figure 1). These lesions can be large and technically
challenging to remove due to size, location, and fibrosis. The
frequency of invasive cancer in homogeneous granular lateral
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FIGURE 1 | (A) Granular lateral spreading lesion; (B) Granular lateral spreading lesion with dominant nodule; (C) Non-granular lateral spreading lesion. These lesion
have a higher risk of fibrosis and invasive cancer. Polyp was tubular adenoma; (D) Non-granular lateral spreading lesion on white light; (E) Non-granular lateral
spreading lesion on Narrow Band Imaging (NBI). Histology revealed a T1 adenocarcinoma.

classification, polyps can be classified as protruding (0-Is—sessile,
0-Ip—pedunculated, and Isp—semi-pedunculated), flat (elevated
0-IIa, flat 0-IIb, and depressed 0-IIc) and excavated (Type 0-III).
The type 0-III lesions are uncommon in the colon. Depressed
lesions have an increased risk of malignancy (30–50% of cases).
Combining Paris classification and the LSL classification can
help guide risk of SMIC. Endoscopic assessment of surface
characteristic can be assisted by “real-time” manipulation of
wavelengths that enhance blood vessels and delineate surface
features [e.g., narrow band imaging (NBI); Olympus, Center
Valley, PA and Fujinon Blue Light Imaging; Fujinon, Valhalla,

spreading lesions (G-LSL) tends to be lower (<5%) than for
G-LSL with a dominant nodule and for non-granular LSL
(NG-LSL), which are flat or pseudo-depressed, as well as large
sessile and bulky lesions of similar size (Figure 2) (35, 37).
Current US Multi-Society Task Force guidelines recommend
endoscopic lesion assessment by using aids such as the Paris
classification, virtual chromoendoscopy (such as Narrow Band
Imaging, or dye spray chromoendoscopy (Kudo classification)
for detection of features suggestive of deep SMI. The Paris
classification is a morphological classification of polyps that can
predict invasive disease risk in lesions (38). Based on the Paris
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FIGURE 2 | Paris is lesion in the rectum. (A) Seen on white light; (B) Seen on Narrow Band Imaging (NBI); (C,D) Polyp raised and resected en bloc. Histology revealed
a superficial (<1 mm) T1 tumor with lymphovascular invasion.

are further divided based on the histopathological feature. The
Kikuchi classification system describes submucosal invasion in
sessile and flat malignant colorectal polyp by dividing submucosa
into three levels: sm1 describes invasion into the upper third
of submucosa, sm2 describes invasion into the middle third of
submucosa and sm3 describes invasion into the lower third of
submucosa. The penetration of cancer cells into sm3 is associated
with a higher risk of lymphatic spread. This implementation of
this classification is challenging as it depends upon the quality
of resected specimen as the entire submucosa is not typically
included in the specimen (46, 47). The Haggitt criteria, used
mainly for pedunculated polyps, classifies polyps into 0–4 levels
based on the depth of invasion. In level 0, dysplastic cells are
limited to the mucosa, level 1 indicated invasion of cancer cells
into submucosa but limited to head of polyp; level 2 indicates
invasion of cancer cells into neck of the polyp; level 3 indicates
when cancer cell invade stalk of the polyp, and level 4 indicate
when cancer cells invade submucosa below stalk of polyp but
above muscularis propria. All non-pedunculated polyps with
any degree of submucosal indicate level 4. The higher depth of
invasion is found to be associated higher incidence of lymph

NY] or by postprocessor technologies that recreate the image
as per the desired wavelengths (e.g., Fujinon Linked Color
Imaging and Pentax iscan; Pentax Medical, Montvale, NJ)
(32, 39). The Narrow Band Imaging International Colorectal
Endoscopic (NICE) classification allows examination of the
surface characteristic of a polyp based on surface appearance,
color and vessel pattern. The NICE classification is highly
accurate in classifying polyps into type 1 (hyperplastic), type
2 (adenoma), and type 3 (invasive cancer) (Figure 3) (40–
43). For the latter, the NICE criteria carry a high specificity
but low sensitivity. In order to overcome this limitation, the
Japanese Narrow Band Imaging Expert Team (JNET) further
divides type 2 into JNET 2a (conventional adenoma) and
JNET 2b (adenoma with high grade dysplasia or superficial
SMIC) (Figure 4) (44). The WASP criteria, based also on
NBI findings, was developed to help identify sessile serrated
lesions (Figure 5). A lesser used tool in the United States,
the Kudo Pit Pattern Classification, uses a combination of
magnifying colonoscopy with dye spray (Indigo Carmine and
Cresyl Violet) to highlight the pit pattern and determine the risk
of deep submucosal invasion (45). Malignant colorectal polyps
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FIGURE 3 | (A) NICE type I (hyperplastic polyp); (B) Paris I-s, NICE type II (tubular adenoma without high grade dysplasia); (C) Paris IIa + is lateral spreading lesion,
NICE type II (tubulovillous adenoma without high grade dysplasia); (D) NICE type III (adenocarcinoma) as see on white light. Note the invisible surface pattern with
avascular area, highlighted in yellow; (E) NICE type III (Adenocarcinoma) as see under NBI.

FIGURE 4 | (A) Paris 0-IIa lateral spreading lesion; (B) On NBI, lesion classified as a JNET 2B. Histology revealed tubular adenoma with high grade dysplasia.

node invasion. Like the Kikuchi classification, this classification
system also depends on the resected specimen’s quality, as if a
pedunculated polyp is resected through the stalk, it will limit the
classification (48, 49).
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According to the 2019 Japanese Society for Cancer of the
Colon and Rectum (JSCCR) guidelines, early CRC (cT1) is
further categorized into slightly invasive cT1 and deeply invasive
cT1. Deeply invasive cT1 is defined based on the endoscopic
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FIGURE 5 | Sessile serrated polyp on white light (A) and narrow band imaging (B). Polyp lacks a brown coloration and blood vessels or a tubular/branched surface
pattern seen with tubular adenomas. Features of SSPs include clouded surface, indisctinctive borders, irregular shape, dark spots inside crypts, and mucus cap.

Assessment of the Technical Difficulty

findings such as fullness, erosion, ulcer, deformity, rigidity,
and full convergence on white light; contrast imaging; dye
chromoendoscopy or image enhanced endoscopy (e.g., NBI,
BLI); and endoscopic ultrasound findings. Deeply invasive
cT1 lesions are managed with surgical resection with varying
degrees of lymph node dissection due to high risk of
lymph node metastasis. Slightly invasive cT1 (cTis) can be
managed with endoscopic treatment through EMR or ESD
when en bloc resection is possible due to low risk of
lymph node metastasis. Whenever en bloc resection is not
possible, these lesions are managed surgically. Even when
endoscopic resection is successful, tumors with unfavorable
histological features need lymph nodes dissection. These include:
positive vertical margin, deep invasion (T1b, submucosal
invasion ≥1,000 µm), poorly differentiated adenocarcinoma,
signet-ring cell carcinoma, or mucinous carcinoma, and
budding grade of BD2/3 at the site of deepest invasion (50,
51).
As per the American Joint Committee on Cancer (AJCC),
early colorectal lesions, including malignant colorectal polyps,
are defined as cancer invading through the muscularis mucosa
into the submucosa (T1). This is further subclassified into
T1a when the lesion is restricted to muscularis mucosa
and T1b when the lesion is extending to submucosa. In
patients with T1a lesions with low-risk features (well-or
moderately differentiated adenocarcinoma, resection margins
free of dysplasia or cancer, ≤2 mm depth of submucosal
invasion, absence of angiolymphatic invasion), endoscopic
management with EMR or ESD is sufficient if en bloc
resection with negative margins can be achieved. However,
for the patients with high-risk lesions and or T1b (poorly
differentiated adenocarcinoma, cribriform pattern, >2 mm depth
of submucosal invasion, lymphatic invasion, and tumor budding)
surgical resection with lymph node dissection is recommended
since they have a risk of lymph node metastasis (52–
54).

Frontiers in Medicine | www.frontiersin.org

The second step in the resection of complex polyps is based on
the assessment of the technical difficulty. It is well-recognized
that incomplete resection is common, increases the difficulty
for subsequent EMR or ESD, and is a risk factor for the
need for surgical resection. The SMSA scoring system (size–S,
morphology–M, site–S, and access–A) is a simple clinical score
that helps to predict the difficulty in polypectomy and identify
patients who are at increased risk of incomplete resection,
adverse events, and recurrence based on the above-mentioned
polyp characteristics (55–57).
Complex polyps should be managed by expert endoscopists
with training in advanced polypectomy techniques in a
multispecialty setting due to higher risk of complications like
bleeding compared to conventional polypectomy; to minimize
the risk of residual polyp/recurrence; to avoid unnecessary
surgeries for benign polyps, and to achieve optimal oncologic
resection in case of malignant polyps (26).

SURGICAL RESECTION
It is extremely important to identify malignant polyps prior to
endoscopic resection to provide the best outcomes, as polyps
with deep submucosal invasion are best treated with surgical
resection. However, many patients in the United States still
undergo surgical resection for benign colon polyps, independent
of age, race, sex, or ethnicity (58). In an analysis of a large,
nationally representative sample, it was found that surgery
for nonmalignant colorectal polyps has significantly increased
from 5.9 in 2000 to 9.4 in 2014 per 100,000 adults (incidence
rate difference, 3.56; 95% CI 3.40–3.72) (58). Unnecessary
surgical management results in increased morbidity, mortality,
and direct and indirect costs (59, 60). In a large multicenter
study, endoscopic management of large LSL by EMR was
significantly more cost-effective than surgery, with a mean cost

6

January 2022 | Volume 8 | Article 728704

Mann et al.

Complex Polypectomy

COMPLEX POLYPECTOMY

saving of $7,602 per patient (95% CI: $8,458–$9,220) and a
reduction of inpatient hospitalization length of stay by 2.81
nights per patient (95% CI: 2.69–2.94) (60). A prospective study
from National Surgical Quality Improvement Program included
12,732 patients who underwent elective surgery to remove the
non-malignant colorectal polyps. This study showed that the
overall risk of 30-day mortality was 0.7%, and the risk of
one or more major postoperative adverse events was 14%. The
index surgery resulted in ostomy among 2.2% of the study
population (61).

Although most of the complex polyps are benign, and >90%
of these can be safely resected endoscopically, assessment of
malignancy should be determined first, as deeply invasive
cancer should be removed surgically for complete resection
and histologic assessment of lymph nodes to determine lymph
node metastasis. Visual signs suggestive of malignancy on
colonoscopy evaluation include induration, friability, ulceration,
and fixation to the colonic wall. However, large polyps can have
invasive carcinoma without these signs (24, 66–70). Technique
selection varies based on location, the lesion’s morphology,
patient’s comorbidities, and endoscopist skills (71, 72). Advanced
endoscopic techniques include EMR, ESD, hybrid techniques
such as pre-cut EMR, Hybrid ESD, and novel therapies such as
endoscopic full-thickness resection.

Transanal Minimally Invasive Surgery
For the last 3 decades, trans-anal endoscopic microsurgery
(TEM) has been the primary treatment for large, benign lesions
of the rectum. However, the cost and technical complexity of
the procedure limits its general use by colo-rectal surgeons.
Transanal minimally invasive surgery (TAMIS) is a minimally
invasive technique for resection of rectal tumors and was first
described in 2009 by Atallah et al. as an alternative to TEM. EMR
and ESD provide an endoscopic alternative for treating complex
rectal lesions (62). There is very limited data comparing TAMIS
with ESD.
In a single-center uncontrolled prospective study conducted
in Germany, 330 patients referred for endoscopic resection
of rectal large non-pedunculated colorectal polyps (LNPCPs)
were included. ESD was performed in 302 patients with rectal
LNPCPs, and the remaining 28 patients (advanced cancer was
suspected macroscopically in 20 patients and benign lesion in 8
patients) were included. The resected lesion showed submucosal
invasive cancer (SMIC) in 52 patients (17.2%) and benign lesions
in 250 patients (82.8%). For SMIC, en bloc, R0, and curative
resection were achieved in 81.4, 65.1, and 30.2% cases. Over the
course of the study period, the curative resection rate increased
from 13.6 to 47.6%, p = 0.036. En bloc and R0 resection for
benign lesions was achieved in 83.2 and 70% cases, respectively.
The total recurrence rate was seen in 4.8% cases for benign
lesions after ESD (63). Quaresima et al. conducted a prospective
study of 31 patients who underwent single-port TAMIS for
mid and high rectal tumors. TAMIS was successfully completed
in all cases without conversation into transabdominal surgery.
The overall complication rate was 9.6%, including one case of
urinary tract infection, one subcutaneous emphysema, and one
hemorrhoidal thrombosis. R0 resection was allowed in 96.8%
of cases with TAMIS. At a mean follow-up of 30 months, a
single case of local recurrence occurred after large adenoma
resection (64).
A multicenter randomized controlled trial (NL7083) is
currently ongoing in Netherlands comparing TAMIS and ESD
for the resection of non-pedunculated rectal lesions >2 cm
size, with the bulk of lesion located below 15 cm from the
anal verge (65). A target sample size is 198 patients who
would be randomized into TAMIS and ESD arms. The primary
endpoint is the recurrence rate at follow-up colonoscopy at 6
months. Secondary endpoints include radical (Ro-) resection
rate, perceived burden and quality of life, cost-effectiveness,
surgical referral rate, overall complication rate, and recurrence
rate at 24 months (65).

Frontiers in Medicine | www.frontiersin.org

APPROACH AND RESECTION
TECHNIQUES
Endoscopic Mucosal Resection
Endoscopic mucosal resection (EMR) is a technique that involves
the removal of lesions within the mucosa (71). EMR technique
involves submucosal injection of a solution into submucosal
space, thus lifting lesion away from the muscularis propria
of the colon, followed by cautery snare resection (Figure 6)
(12, 73). Cold snare EMR is a widely used technique for
polyps sized <10 mm, with emerging data that supports its use
for polyps between 10 and 20 mm and even beyond 20 mm,
specially for serrated lesions (Figure 7) (18, 74–76). There are
various solutions available for submucosal injections, with sterile
normal saline being most frequently used. Other injectable
solutions include saline with epinephrine, fibrin glue, hyaluronic
acid, hydroxypropyl methylcellulose, succinylated gelatin and,
glycerol (77–81). Vital dyes like methylene blue or non-vital
dyes like indigo carmine help identify the deep muscular
layer injury or perforation (82, 83). A meta-analysis of five
randomized controlled studies showed a significant increase
in en-bloc resection (OR 1.91, 95% Cl: 1.11–3.29, P = 0.02)
and fewer residual lesions (OR 0.54, 95% Cl: 0.32–0.91, p
= 0.02) with viscous solutions compared to normal saline
used for submucosal injection for EMR (84). The US multisociety task force on colorectal cancer recommends the use of
a viscous injection solution (e.g., hydroxyethyl starch, Eleview R
submucosal injectable composition, ORISETM Gel Submucosal
Lifting Agent, Boston Scientific) for lesions ≥20 mm to remove
the lesion in a piecemeal fashion with less procedure time
compared to normal saline (Figure 8). It also recommends the
use of contrast agents, such as indigo carmine or methylene blue,
in the submucosal injection solution to facilitate recognition of
the submucosa from the mucosa and muscularis propria layers
(85). Lesions are removed by snare excision either as en-bloc
resection or piecemeal polypectomy, depending on size and
morphology (Figure 9). A meta-analysis of 50 studies, including
6,442 patients with colorectal polyps ≥20 mm treated with EMR,
showed an initial success rate of 92% for endoscopic resection,
and only 8% of patients underwent surgery due to non-curative
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FIGURE 6 | (A,B) Paris 0-IIa lesion, injected with methylene blue, size noted to be larger than originally suspected; (C,D) En-bloc endoscopic mucosal resection with
blended coagulation current and a 20 mm snare.

FIGURE 7 | (A) Sessile serrated lesion injected prior to resection to better define resection borders; (B,C) Sessile serrated lesion removed by dynamic submucosal
injection and piecemeal cold endoscopic mucosal resection.

endoscopic resection. Endoscopic recurrence, perforation and
bleeding occurred in 13.8, 1.5 and 6.5%, respectively (86). Studies
have shown that EMR is not only cost-effective than surgery;
it has less morbidity and mortality also (Table 1). It should be
considered the first line of treatment for patients with these sessile
or lateral spreading large (≥20 mm) lesions (60, 87).

Frontiers in Medicine | www.frontiersin.org

En-bloc resection is preferred over piecemeal polypectomy
as it allows more accurate histological assessment. In cases of
malignant polyps, it gives fundamental information on lateral
and vertical margins. Deep submucosal invasion, defined as
tumor involvement ≥1 mm (1,000 mm, or SM3 on Kikuchi
classification), is associated with a high risk of lymph node
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FIGURE 8 | (A) Submucosal injection using ORISETM gel submucosal lifting agent (Boston Scientific). (B) Submucosa easily identify with indigocarmine non-vital stain.

conventional technique. The disadvantage of this technique is
bleeding underwater during resection can obscure visualization
(118, 119).

metastasis and residual recurrence (10–18%) (114). A metaanalysis of 33 studies showed the overall recurrence risk for EMR
resection to be 15% (95% Cl 12–19%). The recurrence rate was
higher after piecemeal resection (20%) than en-bloc resection
(115). A multicenter prospective study of 1,000 successful EMR
procedures for sessile or laterally spreading colonic lesions
≥20 mm in size showed an early recurrent/residual adenoma
rate of 16% (95% Cl: 13.6–18.7%) (116). Out of the total,
71.7% of these were diminutive, and 93.1% treated successfully
using the endoscopic method. Lesions size >40 mm, use of
argon plasma coagulation (APC) for treatment of incomplete
polyp resections, and intraprocedural bleeding was identified
as risk factors for these recurrent/residual adenomas (116).
Consequently, surveillance endoscopy is recommended at 6 and
at 16–18 months after piecemeal EMR to detect any recurrence
(117). The US Multi-Society Task Force on Colorectal Cancer
recommends using adjuvant thermal ablation at the margins of
the polypectomy, even when there is no endoscopically visible
polypoid tissue for treatment of micropolyp not visible by
endoscopy (39). The most common modalities include APC or
snare tip soft coagulation. Residual polypoid tissue within the
polypectomy site is best treated by avulsing the residual polyp
using hot forceps called as hot forceps avulsion technique (39).
Another technique, underwater EMR is also gaining in
popularity. Different from conventional injection assisted EMR,
where submucosal injection provides a cushion separating
the submucosal layer form the muscularis propria (MP), no
submucosal injection is performed during underwater EMR
to raise the lesion. The polyp is submersed in water and the
intraluminal air removed, removing colonic wall tension, and
separating the mucosa from the MP. This prevents accidental
muscle entrapment with the snare and helps with thermal
dissipation, decreasing the risk of perforation during resection.
Additional advantages of this technique is that it allows the
capture of a larger mucosal surface area in the opened snare,
increasing the chance of en-bloc resection without the use of a
larger snare, and the resection is faster than compared to the
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Endoscopic Submucosal Dissection
Endoscopic submucosal dissection (ESD) is an advanced form
of polypectomy designed to resect large lesions in an en-bloc
manner resulting in lower recurrence rates (120, 121). It was
initially described in Japan for resection of early gastric cancer
and now adopted to treat complex colorectal polyps (122,
123). ESD allows en-bloc resection of large superficial polyps,
especially flat polyps, which would otherwise need piecemeal
resection with EMR. A piecemeal resection by EMR lead to
increased recurrent rates when compared to en-bloc ESD (124,
125). ESD involves a submucosal injection to achieve adequate
submucosal lift and then circumferential incision of mucosa
using an endoscopic knife, followed by submucosal dissection
underneath the lesion above the muscularis propria (73,
117, 126). ESD is time-consuming, labor-intensive, technically
difficult, and has a higher risk of complications like bleeding or
perforation (71, 117).
American Gastroenterology Association recommends ESD for
colorectal lesions which are too large to ensure en bloc resection
with EMR or at higher risk of containing cancer (125). Similarly,
the European Society of Gastrointestinal Society recommends
that ESD to be considered in patients with colonic and rectal
lesions suspected to have a superficial submucosal invasion (sm1
and sm2), which cannot be removed en-bloc by EMR technique
(127). Lesions with suspicion for deep submucosal invasion
(sm3) or muscualris propria invasion should be referred for
surgical management. The greatest benefit of ESD is in rectal
lesions. ESD offers a minimally invasive option with adequate
R0 resection in selected early rectal cancers (T1,where in cancer
is restricted to the submucosa) with no high risk histologic
features, ESD has also shown great results in the management
of residual/recurrent tumors after EMR, tumors in patients with
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FIGURE 9 | Piecemeal endoscopic mucosal resection. (A) A 40 mm Paris 0-IIa, granular lateral spreading lesion in the cecum seen on white light; (B) Same lesion
seen under narrow band imaging; (C–G) Polyp removed by dynamic and piecemeal injection using a blended cutting current. The histology showed tubular adenoma.
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TABLE 1 | Endoscopic mucosal resection (EMR) for colon polyp studies with more than 100 patients.
References

Study type

Number of
patients

En bloc resection
rate (%)

Piecemeal
resection (%)

Prospective

252

30

70

Complications (%)

2000–2010
Church (88)

Late bleeding-6.74, perforation-0, post-polypectomy
syndrome-0.79

Doniec et al. (89)

Prospective

184

11

89

Bleeding-2, perforation-0.5

Conio et al. (90)

Prospective

136

0

100

Intraprocedure bleeding-10.8, perforation-0

Perez Roldan et al. (91)

Retrospective

142

49

51

Bleeding-5.4, perforation-1.3

Uraoka et al. (92)

Retrospective

211

56.05

n/a

Immediate bleeding-4, delayed bleeding-4.9, perforation-0.4

Overhiser and Rex (93)

Retrospective

184

15

85

Delayed bleeding-7.3, perforation-1.1, post-polypectomy
syndrome-0.6
Bleeding-1.7, perforation-0

Arebi et al. (94)

Retrospective

161

0

100

Swan et al. (95)

Prospective

174

33.53

66.1

Delayed bleeding-3.7, perforation-0

Khashab et al. (96)

Retrospective

132

0

100

Delayed bleeding-4.5, perforation-0

Luigiano et al. (97)

Retrospective

148

43.9

56.1

Procedural bleeding-10.14, perforation-0.68,
post-polypectomy syndrome-1.35

Conio et al. (98)

Prospective

255

0

100

Intraprocedural bleeding-7.4, perforation-0, post-coagulation
syndrome-0.3

Saito et al. (99)

Retrospective

228

33

67

Delayed bleeding-3.1, perforation-1.3

2011–2020
Tajika et al. (100)

Retrospective

104

83.5

n/a

Bleeding-2.9, perforation-0

Buchner et al. (101)

Retrospective

274

53.5

46

Acute bleeding-3.38, delayed bleeding-7.2,
microperforation-0.36

Kim et al. (102)

Retrospective

497

72.4

27.6

Procedural bleeding-18, post-EMR bleeding-2,
perforation-0.4

Lee et al. (103)

Retrospective

140

42.9

57.1

Bleeding-0, perforation-0

Serrano et al. (104)

Retrospective

133

56.4

43.6

Intraprocedural bleeding-4.3, delayed bleeding-0.7,
perforation-0.7

Belle et al. (105)

Retrospective

147

58

24

Bleeding-14, perforation-8.8

Bronsgeest et al. (106)

Retrospective

343

18.7

81.3

Bleeding-6.9, perforation-1.2

Pellise et al. (107)

Prospective

1,671

15.8

84.2

Bleeding-n/a, perforation-0.48

Zhang et al. (108)

Prospective

179

95

5

Bleeding-1.65, perforation-n/a

Iwashita et al. (109)

Retrospective

731

n/a

n/a

Yamashina et al. (110)

Prospective

102

76

26

Rashid et al. (111)

Retrospective

480

19.2

74.4

Delayed bleeding-0.7, perforation-0
Delayed bleeding-1.96, perforation-0
Intraprocedural bleeding-4.8, delayed bleeding-1.67,
perforation-0.21

van Hattem et al. (112)

Prospective

353

0

100

Delayed bleeding-5.1

Zhang et al. (113)

Retrospective

130

92.96

7.04

Bleeding-1.4, perforation-0

successful en-bloc resection in 84.91% (95% Cl: 77.82–90.82)
and complete cure en-bloc resection in 75.39% (95% Cl: 66.69–
82.21) (131) (Table 2). Another systematic review and metaanalysis of 97 studies evaluating colorectal lesions resected
using the ESD technique showed that the R0 resection rate
was 82.9% (95% Cl: 80.4–85.1%) and significantly higher in
Asian countries than non-Asian countries (85.6 vs. 71.3%).
Similarly, the en-bloc resection rate was 91% (95% Cl 89.2–
92.5%), which was also significantly higher in Asian countries
than non-Asian countries (93 vs. 81.2%). The complication
like recurrence at 12 months (2%), delayed bleeding (2.7%)
and perforation (5.2%) were significantly low (132). ESD
is an established endoscopic resection method in Asian
countries and being slowly adopted in Western countries
with increasing practice in Europe over the last decade

inflammatory bowel disease, and large colo-rectal polyps (128,
129).
There are 2 different techniques in ESD: the classical technique
and the submucosal tunneling technique. The classical technique,
with an initial circumferentially dissection around the polyp
followed by dissection under the polyp and complete resection
of the lesion. The submucosal tunnel leads to the creation of
a pocket. The proximal end of the polyp is dissected initially
and subsequently, the distal end is raised. The lateral end is not
dissected at the beginning to avoid loss of injection fluid and the
polyp raise is maintained. An inicision from the distal end is then
used to create a tunnel and complete the dissection. Toward the
end of the dissection, the lateral walls are dissected (130).
A meta-analysis of 14 studies evaluating the success of
en-bloc resection of large colorectal polyps by ESD showed
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TABLE 2 | Endoscopic submucosal dissection (ESD) for colon polyp studies with more than 100 patients.
References

Study type

Number of
patients

En bloc resection
rate (%)

R0 resection
rate (%)

Complications (%)

2009–2014
Isomoto et al. (133)

Retrospective

278

90.1

79.8

Hotta et al. (134)

Retrospective

120

93

85

Perforation-7.5, bleeding-N.A PMID-21175483

Nimmi et al. (135)

Retrospective

290

90.3

74.5

Post-operative bleeding-1.3 and perforation-4.5

Matsumoto et al. (136)

Retrospective

203

86

86

Bleeding- 0, perforation-7 PMID-20626303

Kuroki et al. (137)

Retrospective

418

98

92

Bleeding-2, 4 perforation-5.26

Bleeding-0.7, perforation-8.2

Toyonaga et al. (138)

Retrospective

268

99

98

Bleeding-0.37, perforation-2.2

Nishiyama et al. (139)

Retrospective

282

89.2

79.1

Bleeding-0.7, perforation-8.1

Saito et al. (140)

Retrospective

1,090

88

89

Postoperative bleeding-1.5, perforation-4.9

Yoshida et al. (141)

Retrospective

250

87

81

Post-operative bleeding-2.4, perforation-6

Byeon et al. (142)

Retrospective

162

87

75

Shono et al. (143)

Retrospective

137

89.1

85.4

Immediate bleding-1, delayed bleeding-1, and perforation-7.4
Perforation-3.6, post-operative hemorrhage-3.6

Sakamoto et al. (144)

Retrospective

101

94

92

Bleeding-0, perforation-1.98

Tamai et al. (145)

Retrospective

614

89.4

87.1

Bleeding 1.4, perforation-2.6

Kiriyama et al. (146)

Retrospective

297

87.2

80.1

Post-procedure bleeding-1.7, perforation- 4.7

Lee et al. (147)

Retrospective

874

97.5

91.2

Perforation-5.3

Nakajima et al. (124)

Prospective

816

94.5

93

Delayed bleeding 2.2, perforation-1.6

Suh et al. (148)

Retrospective

150

98

95.3

Perforations-4.7, delayed bleeding-0

Hori et al. (149)

Prospective

232

93

92

Bleeding-n/a, perforation-2

Nawata et al. (150)

Retrospective

145

99

97

Bleeding-0, perforation-0

Sato et al. (151)

Retrospective

147

94.7

86.8

Sakamoto et al. (152)

Retrospective

164

95

92

Delayed bleeding-3, perforation-4

Takeuchi et al. (153)

Retrospective

816

94

78

Perforation 2.1, bleeding-2.2

Bleeding-1.3, perforation-1.3

2015–2021
Mizushima et al. (154)

Retrospective

122

86.6

87

Delayed bleeding-3.7, perforation-6.7

Tanaka et al. (155)

Retrospective

629

94

92

Bleeding-0.79, perforation-3.1

Yamamoto et al. (156)

Retrospective

107

97.5

91

Bleeding-1.7, perforation-0.8

Hayashi et al. (157)

Retrospective

472

98

87

Bleeding-2.2, perforation-4

Cong et al. (158)

Retrospective

156

83

81

Perforation-2.3, bleeding-3.4

Shigita et al. (159)

Retrospective

222

89.7

83.0

Bleeding-6.3, perforarion-5.4

Sauer et al. (160)

Retrospective

178

88.4

89.4

Youk et al. (161)

Prospective

319

98

80

Perforation-0.6, bleeding-3.1

Delayed bleeding-2.7, perforation-9.3

Spychalski et al. (162)

Prospective

227

79.39

79

Bleeding 4.4, perforation-7.9

Iacopini et al. (163)

Prospective

155

83

71

Delayed bleeding-1, perforation-3

Yamada et al. (164)

Retrospective

423

n/a

81

Boda et al. (165)

Retrospective

1,233

92.6

83.7

Ronnow et al. (166)

Retrospective

301

80

69

Qi et al. (167)

Retrospective

412

99.5

86.9

Delayed bleeding-1 and perforation 3
Delayed bleeding-3.7, perforation-intraoperative-3.4, and
delayed perforation-0.4
Bleeding-3 and perforation-14
Bleeding-2.2, perforation-1, post-ESD electrocoagulation
syndrome-6.8

Yang et al. (168)

Retrospective

171

82.5

74.9

Bleeding-2.3, perforation-4.1

Tanabe et al. (169)

Prospective

141

91.8

N/A

Delayed bleeding-7.8, perforation-2, post-colorectal ESD
coagulation syndrome-4.3

Draganov et al. (170)

Prospective

692

91.5

84.2

Bleeding-2.3 and perforation-2.9

R0, Radical resection rate; Defined as dysplasia free vertical and lateral resection margins at histology.

95% CI 0.16–0.2) (171). Similar results were reported in other
meta-analyses showing higher en bloc resection rates with ESD
compared to EMR (99, 172). There are several advancements
in endoscopic tools which have made ESD less cumbersome.
There are various colonic dissection knives (dual knife, dual-J

and now in the United States, mainly in advanced tertiary
centers (125).
A meta-analysis of 66 studies comparing EMR and ESD
for colorectal lesions showed higher en bloc resection rate of
90.5% with ESD compared to 62.8% with EMR (OR 0.18,
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dehiscence due to OVESCO clip falling off the colonic mucosa
thereby leading to peritonitis and sepsis. Most of the data is from
small studies, so further large, randomized studies are needed,
especially compared with other available endoscopic resection
techniques (178–181).

knife, Hook knife, IT knife, IT-J knife, ERBE knife) and coagulation grasping forceps for co-agulation of bleeding. However,
the traction tools are still lacking making it a challenging
procedure (173).

Hybrid ESD or Knife Assisted Snare
Resection

SPECIMEN HANDLING

It combines ESD with snaring and thus simplifies the process
of submucosal dissection. It is associated with shortening time
to perform the procedure and complication rate, although it has
lower en-bloc resection rates than typical ESD (174). It involves
using an ESD knife to make a circumferential mucosal incision
around the lesion, and then the targeted subepithelial lesion is
grasped, retracted toward the lumen, followed by snare resection.
Resection is aimed for en-bloc removal. This technique uses
a standard snare, and needle-knives during ESD (12, 130). It
can also be used to resect scarred polyps (recurrence following
previous EMR) (12).
Retrospective data was collected from a study in Japan
conducted in patients with large colorectal polyps with size
>20 mm who underwent either ESD (for 137 lesions in 134
patients) or hybrid ESD (27 lesions in 26 patients). Results
showed a shorter procedure time with hybrid ESD (108 ± 59.5 vs.
122 ± 72.2 min) but lower en-bloc resection than the ESD group
(66.7 vs. 94.2%). However, there were no significant differences
in procedure time, in rates of en bloc resection or complication
rates between the two groups (174).
In a meta-analysis, 97 studies evaluated standard technique,
and 12 studies evaluated hybrid technique for colorectal lesions
suspicious of superficial malignancy showed that R0 and enbloc resection rate of 60.6 and 68.4%, respectively, for hybrid
technique. It was significantly lower than the standard ESD
technique with similar adverse event rates (132). Another recent
meta-analysis of 16 studies with 751 patients who underwent
hybrid ESD for large colorectal lesions showed an en-bloc
resection rate and complication rate of 81.63% (95% Cl: 72.07–
88.44) and 7.74% (95% Cl 4.78–12.31), respectively. Subgroup
analysis of conventional (N = 1,703) with hybrid ESD (N = 497),
procedure time was found to significantly shorter with hybrid
ESD (mean difference 18.45 min; p = 0.003), lower complication
rate (p = 0.04), but it has lower en bloc resection rate (p <
0.001) (175).

Pathological examination of specimens resected by EMR or
ESD is a critical step and crucial for diagnosis of lymphatic
spread and risk of metastasis. A clinical report with endoscopic
information and a pinned formalin-fixed specimen with margins
properly oriented by an endoscopist are necessary to start
pathologic assessment (182, 183). The specimens are pinned onto
a paraffin wax block and submerged in formaldehyde before
submitting for the pathologic assessment to preserve tissue shape,
size, and orientation. Knowledge about the appearance of the
lesion is required to have the orientation of the specimen.
To help orientation of en bloc resection specimens, these
specimens are first flattened and fixed at their periphery with thin
needles before immersion to formalin. The distance of cancerous
tissue from the resection margin should be included for
pedunculated specimens. Similarly, non-pedunculated cancerous
lesion specimens should include the histology, depth of the
lesion, cancerous involvement of the lateral and vertical margins,
presence of tumor budding, degree of pathologic differentiation,
and lymphatic and blood vessel involvement (39).

COMPLICATIONS
These advanced endoscopic techniques for the removal of
complex polyps have an increased risk of various complications.
Bleeding and perforation are two main complications associated
with EMR and ESD procedures. Other complications include
non-specific postprocedural pain, post polypectomy syndrome,
residual tissue. It is very important for the endoscopists to
prevent, early recognition and prompt management of these
complications (Tables 1, 2).

Bleeding
Bleeding is the most common complication after the EMR
procedure, reported in 0.7–24% of the cases. It can be classified
into immediate post-polypectomy–IPPB (intraprocedural) or
delayed post-polypectomy–DPPB (post-procedural) bleed (184).
Intraprocedural bleeding has been reported in 11–22% of cases,
and it can be controlled endoscopically, but it does prolong
the procedure (72, 83, 185). The risk factor for intraprocedural
bleeding includes large polyps, tubulovillous or villous lesion,
minimally elevated sessile polyps, limited operator experience
with EMR. This bleeding is effectively managed during the
procedure using snare tip soft coagulation, coagulation grasping
forceps, or endoclips (72, 186). Postprocedural bleeding occurs
hours to days after the procedure, and the rate of bleeding has
been reported between 2 and 11%, with clinically significant
bleeding in 6% of the cases (72, 83, 185). Risk factor for delayed
bleeding includes lesions in the right colon, large lesions with size
≥40 mm, age more than 75 years, antiplatelets or anticoagulants

Endoscopic Full-Thickness Resection
This is another well-established advanced resection technique.
The EFTR involves full-thickness plication of the bowel wall
secured by an over-the-scope clip followed by bowel wall
resection above the clip. Commercially available full-thickness
resection device (FTRD R , Ovesco, Germany) is a single-step
full-thickness device that combines a modified over-the-scope
clip with an integrated snare (176). EFTR is for complex polyp
that is not amenable to conventional endoscopic resection due
to severe fibrosis and scarring, specific anatomical locations
(close to a diverticulum or appendiceal orifice), and cases of
incomplete resections. Lesions <2.5 cm are suitable for this
technique (126, 177). There is a small risk of appendicitis when
lesions are resected close to the appendix and some risk of
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within seven days of procedure and intraprocedural bleeding
(83, 187–189).
The bleeding rate after ESD ranges from 0 to 11.9% for
upto 15 days post procedure. It can be classified into immediate
(intraprocedural) or delayed (post-procedural) bleed (190, 191).
A recent meta-analysis of 104 studies showed the rate of
immediate and delayed major bleeding of 0.75% (95% Cl: 0.31–
1.8%) and 2.1% (95% Cl: 1.6–2.6%), respectively, after ESD for
colorectal lesions (192). Risk factors for delayed bleeding include
the lesion’s size, sessile type, the occurrence of intraprocedural
bleeding, use of prior anti-thrombotic agents (193, 194). Recent
studies have shown lesions in the cecum and rectum have a higher
incidence of delayed bleeding after ESD (193, 195, 196).
Several randomized studies have evaluated the utility of clip
closure after resection of large non-pedunculated colonic polyps
(197–199). Results of these studies argue against the routine use
of prophylactic clip placement after polypectomy. However, clip
closure is recommended to prevent DPPB after resection of large
colorectal lesion ≥20 mm in size and proximal to the splenic
flexure (200). Closure of lesion ≥20 mm is further supported by a
recent meta-analysis of 13 studies that showed that prophylactic
clipping (1.4%) was associated with a lower rate of delayed
bleeding compared to no clipping (5.2%) (pooled OR:0.24, 95%
Cl: 0.12–0.50) after the EMR procedure (201).

210). In selected cases, endoscopic suturing devices (Overstitch
Endoscopic Suturing SystemTM , Austin, Texas, USA), which
provide full thickness closure, have been used to close larger
lesions (211).

Post-polypectomy Syndrome
Post polypectomy syndrome is an electrocoagulation injury to the
bowel wall after endoscopic treatments, including conventional
polypectomy, EMR, and ESD. Injury to the wall induces a
transmural burn and localized peritonitis, which in turn causes
serosal inflammation (212, 213). Incidence of post polypectomy
syndrome varies from 1% after conventional polypectomy or
EMR to 9% after ESD (212). The patient presents with abdominal
pain, fever, tenderness, leukocytosis, elevated C-reactive protein
after an endoscopic procedure like polypectomy, ESD, or EMR,
without any obvious perforation on abdominal imaging like
radiograph or computed tomography (138, 190, 213). Most
of these patients are successfully managed with conservative
treatment, including bowel rest, broad-spectrum antibiotics, and
hydration. Patients should be reevaluated for possible delayed
perforation in case they are not showing improvement or getting
worse with conservative management (212, 214, 215).

Stenosis
Post-ESD stenosis is defined as narrowing through which a
standard endoscope cannot be advanced (130). Fortunately,
there are only a few studies describing post ESD stenosis after
colorectal ESD. This is mostly seen when more than 75% of the
circumferential lesion is resected. In a retrospective study of 822
patients who underwent colorectal ESD, 0.49% (4/822) of patients
developed stenosis post-procedure. Post-ESD stenosis occurred
in 11.1% of patients who underwent circumferential resection
between ≥90 and 100%, and in 50% of patients who underwent
100% circumferential resection (216). Similarly, in another study
of 69 patients with large rectal neoplasm that required ≥75
% circumferential resection, 19.7% of the patients developed
post-ESD rectal strictures. In the subgroup analysis, patients
who underwent total circumferential ESD developed stricture in
71.4% of cases, and those who underwent ≥90% circumferential
resection developed stricture in 43.8% of cases (217). These
studies showed that ≥90% circumferential resection is a risk
factor for stenosis after colorectal ESD. Most of these patients are
managed by endoscopic balloon dilatation (130, 216, 217).

Perforation
Another potential complication after EMR and ESD is colonic
perforation. The risk of perforation is low after EMR, with
the reported risk of 1–2%. In a meta-analysis of 50 studies,
endoscopic perforation occurred in 1.5% (95% Cl: 1.2–1.7%)
of cases following EMR for colorectal polyps ≥20 mm (86).
Risk factors include using larger diameters snares (≥20 mm),
proximal location, bulky lesions, and cutting current. Perforation
is more common following colorectal ESD, and the rate reported
to be up to 3.3 to 10% (140, 171, 172, 202–204). A meta-analysis
of 66 studies comparing EMR and ESD for colorectal lesions,
perforation rate was found to higher with ESD compared to EMR
(4.8 vs. 0.9%, p < 0.0001) (171). Similar results were reported in
other meta-analyses showing higher perforation risk with ESD
compared to EMR (99, 172). A meta-analysis of 97 studies with
colorectal lesions removed by standard ESD showed a perforation
rate of 5.2% (95% Cl: 4.4–6.1%). This meta-analysis also included
12 studies with colorectal lesions removed by hybrid ESD and
showed a perforation rate of 4.8% (95% Cl: 2.4–9.1%) (132). Risk
factors for perforations during ESD include tumor size, location,
submucosal fibrosis, and operators with limited experience (205,
206). Perforations are more in the ascending colon and cecum
due to its thin wall (207, 208).
Deep muscle injury without overt perforations (Sydney
classification Type 2–3) or small perforations (up to 10 mm)
recognized during colonoscopy can be managed endoscopically
with through the scope clips. Surgery can be avoided for overt
perforations (Type 4–5) up to 30mm by using larger capacity over
the scope clips (Ovesco R , Endoscopy AG, Tübingen, Germany,
or the Padlock Clip R Defect Closure System, Steris HC, OH,
USA); however, it requires surgical intervention if recognized
late or if there is overt contamination (83, 171, 190, 209,
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FUTURE DIRECTION
The main challenges in performing ESD in the west have been
higher prevalence of colorectal polyp requiring ESD, unlike in
Japan where ESD is performed more in the stomach. There is
more prevalence of obesity in the west, which makes the colon
tortuous and thereby procedure technically challenging. The risk
of procedure complications are higher due to thin colonic wall
unlike the thick gastric wall. Therefore, there is a need for more
advanced tools for polyp traction and post polypectomy defect
closure to safely perform the procedure. In US, although there is
increase interest in ESD for colorectal lesions, the adoption has
been slow due to lack of dedicated training in ESD.

14

January 2022 | Volume 8 | Article 728704

Mann et al.

Complex Polypectomy

One of the common traction approaches is the distal
attachment (cap) attached at the endoscope’s end, which helps
move the lesion away and allows visualization of the dissection
plane (12, 218). Various traction devices have been developed to
facilitate faster ESD with a lower complication rate (12, 219). One
simple method to achieve traction is to have a silk line (like a
dental floss) tied to a hemostatic clip to the edge of the lesion and
pulling the lesion proximally using the line away from the colonic
wall to perform a safe dissection. It is a simple method; it does
not require any novel equipment but requires the endoscope’s
reinsertion (220). Internal traction modifies the above method
by attaching a micro-tech elastic band or ring, or nylon to a
clip attached to the lesion and another clip to the opposite end.
No reinsertion of the endoscope is required (221, 222). Another
novel system consisting of an expandable working chamber with
two independent instrument guides (LIG) has been used in the
in vivo model to achieve safe and effective completion of ESD and
submuscular dissection by improving visualization, access to the
target tissue, and improving procedure time (223).
Another technique, thin endoscope-assisted ESD, allows
traction in any direction where the second endoscope is inserted
alongside the main endoscope. At present, this technique is
limited to the distal sigmoid colon and rectum (224). Other
techniques like a three-dimensional printed overtube system with
two manipulator arms at the tip and magnetic traction methods
have shown promising results in animal models (225, 226). Most
of these techniques are not in mainstream use. Clip and string are
commonly used in most ESD practices as they don’t require any
special equipment (12).
Post polypectomy defect closure post resection is another
significant challenge especially in the right side colon. Di-Lumen
or Lumendi is an accessory to the endoscope, which works like
an overtube. This helps in reducing the loop in the colon thereby
ensuring better stability with right side colon polyp resection and
faster access to the lesion especially in the right side of the colon.
The time for resection of large polyps in the right side of the
colon has decreased by nearly 50% due to Lumendi. The overtube
can then be used as a conduit to pass the Apollo overstitch. The
overstitch can usually only reach the left side of the colon, but
because of the reduced loop and the colon being less tortuous

and straight, it is now able to reach the right side of the colon for
safe closure of the post polypectomy defect. The disadvantage in
using an apollo overstitch is that the scope has to be removed,
the suture has to be loaded and the scope again reinserted which
can add to the already prolonged procedure time (227, 228). A
novel suture device called endoscopic tack is now FDA approved
and the post polypectomy defect can be safely closed without
scope removal (229). In addition to the current colonic dissection
knives, there is a new speed boat Knife (Creo Medical) which can
help in simultaneous injection, dissection, and coagulation. This
helps in speedy dissection and en-bloc resection (230).

CONCLUSION
Management strategies for complex polyp have evolved
immensely over the last two decades and continue to do so.
This is due to a better understanding of complex polyps’
pathophysiology and advancement in technology, which led
to the development of novel endoscopic tools and techniques
and more effective management of complications. Whenever
an endoscopist encounters a complex colorectal lesion,
many patient-specific variables like age, comorbidities, use
of anticoagulants and polyp-specific like lesion size, location,
and malignancy risk should be considered before deciding
to either resect or refer to an advanced endoscopist. Most
premalignant lesions can be removed with advanced endoscopist
techniques, but these procedures require an endoscopic expert
in the field, a center with the appropriate equipment, and
trained staff. Management of complex polyp with advanced
endoscopic techniques like EMR, ESD, and hybrid approcahes
will lead to decreased morbidity, mortality, and healthcare
cost by decreasing the need for surgical interventions. This
will prevent unnecessary morbid surgical procedures for
benign lesions.
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